Health
SARS-CoV-2 Mpro inhibitors with antiviral activity in a transgenic mouse model – Science Magazine
Vaccines are an important tool in the fight against COVID-19, but developing antiviral drugs is also a high priority, especially with the rise of variants that…
Abstract
The COVID-19 pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continually poses serious threats to global public health. The main protease (Mpro) of SARS-CoV-2 plays a central role in viral replication. We designed and synthesized 32 new bicycloproline-containing Mpro inhibitors derived from either boceprevir or telaprevir, both of which are approved antivirals. All compounds inhibited SARS-CoV-2 Mpro activity in vitro, with 50% inhibitory concentration values…
-
Noosa News21 hours agoPiccardi Fry Lawyers – Proctor
-
Noosa News14 hours agoAustralian woman becomes instant millionaire with USA Power Lotto win
-
Noosa News23 hours agoRiverfire 2025: What time the fireworks start, where to watch and how to get home
-
Business18 hours agoShould you avoid Nvidia stock?